Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Expert Opinion on Investigational Drugs
|
May 16, 2007
DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials
Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 19, 2014
A clinical update of using albumin as a drug vehicle - a commentary
Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 28, 2008
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
Topics in Current Chemistry
|
April 23, 2013
Acid-sensitive prodrugs of Doxorubicin
Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 22, 2014
WITHDRAWN: A clinical update of using albumin as a drug vehicle - A commentary
Felix Kratz
Angewandte Chemie (International Ed. in English)
|
January 31, 2006
Polymer therapeutics: concepts and applications
Rainer Haag, Felix Kratz
The Journal of Organic Chemistry
|
January 22, 2008
2,4-Bis(hydroxymethyl)aniline as a building block for oligomers with self-eliminating and multiple release properties
André Warnecke, Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 19, 2012
Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems
Felix Kratz, André Warnecke
Bioconjugate Chemistry
|
March 20, 2003
Maleimide-oligo(ethylene glycol) derivatives of camptothecin as albumin-binding prodrugs: synthesis and antitumor efficacy
André Warnecke, Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 14, 2011
Clinical impact of serum proteins on drug delivery
Felix Kratz, Bakheet Elsadek
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Expert Opinion on Investigational Drugs
|
May 16, 2007
DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials
Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 19, 2014
A clinical update of using albumin as a drug vehicle - a commentary
Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 28, 2008
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
Topics in Current Chemistry
|
April 23, 2013
Acid-sensitive prodrugs of Doxorubicin
Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 22, 2014
WITHDRAWN: A clinical update of using albumin as a drug vehicle - A commentary
Felix Kratz
Angewandte Chemie (International Ed. in English)
|
January 31, 2006
Polymer therapeutics: concepts and applications
Rainer Haag, Felix Kratz
The Journal of Organic Chemistry
|
January 22, 2008
2,4-Bis(hydroxymethyl)aniline as a building block for oligomers with self-eliminating and multiple release properties
André Warnecke, Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 19, 2012
Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems
Felix Kratz, André Warnecke
Bioconjugate Chemistry
|
March 20, 2003
Maleimide-oligo(ethylene glycol) derivatives of camptothecin as albumin-binding prodrugs: synthesis and antitumor efficacy
André Warnecke, Felix Kratz
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 14, 2011
Clinical impact of serum proteins on drug delivery
Felix Kratz, Bakheet Elsadek
Page
of 8